0001209191-20-015110.txt : 20200303 0001209191-20-015110.hdr.sgml : 20200303 20200303161153 ACCESSION NUMBER: 0001209191-20-015110 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200302 FILED AS OF DATE: 20200303 DATE AS OF CHANGE: 20200303 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KELLEY SCOTT CENTRAL INDEX KEY: 0001222950 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36287 FILM NUMBER: 20682323 MAIL ADDRESS: STREET 1: C/O ASPECT MEDICAL SYSTEMS INC STREET 2: 141 NEEDHAM ST CITY: NEWTON STATE: MA ZIP: 02464-1505 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Flexion Therapeutics Inc CENTRAL INDEX KEY: 0001419600 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10 MALL ROAD STREET 2: SUITE 301 CITY: BURLINGTON STATE: MA ZIP: 01803 BUSINESS PHONE: (781) 305-7777 MAIL ADDRESS: STREET 1: 10 MALL ROAD STREET 2: SUITE 301 CITY: BURLINGTON STATE: MA ZIP: 01803 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-03-02 0 0001419600 Flexion Therapeutics Inc FLXN 0001222950 KELLEY SCOTT C/O FLEXION THERAPEUTICS, INC. 10 MALL ROAD, SUITE 301 BURLINGTON MA 01803 0 1 0 0 Chief Medical Officer Common Stock 2020-03-02 4 A 0 31000 0.00 A 80365 D Stock option (right to buy) 15.78 2020-03-02 4 A 0 15500 0.00 A 2030-03-01 Common Stock 15500 15500 D Represents restricted stock unit award granted under the Issuer's 2013 Equity Incentive Plan. Twenty-five percent (25%) of the shares shall vest on the one year anniversary of January 1, 2020 (the "Vesting Commencement Date") and thereafter one-forty-eighth (1/48th) of the total shares shall vest each month following the one year anniversary of the Vesting Commencement Date, so that all of the shares shall be vested four (4) years after the Vesting Commencement Date. /s/ Mark S. Levine, Attorney-in-Fact 2020-03-03